PubMed
reference(s)
|
Type of Aberration |
ChiPPI
network |
UniProtKB
fusion |
Gene symbol1
|
Gene symbol2
|
RNAseq,
Mass-spec
evidence |
Cancer type &
Drug Therapy (DT) |
Description of Diseases |
| 1 |
2 |
3 | 4 | 5 | 6 | 7 | 8 | 9 |
21529941
[1]Mitelman[2]
[ChiTaRS*]
1 |
 |
ins(15;17)(q22;q21q26)
| | |
 |
| | |   Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
|
20439630
[1]Mitelman[2]
[ChiTaRS*]
2 |
 |
der(7)(q?)
| | |
|
| | | Acute myeloid leukemia, NOS (AML NOS).
|
20439630
[1]Mitelman[2]
[ChiTaRS*]
3 |
|
der(5)(?)
| | |
|
| | | Acute myeloid leukemia, NOS (AML NOS).
|
| 4 |
|
der(11)(q23)
| | |
|
| | | Acute myeloid leukemia, NOS (AML NOS).
|
| 5 |
 |
inv(16)(p13q22)
| | |
|
| | | Acute myeloid leukemia, NOS (AML NOS).
|
| 6 |
|
ins(17;15)(q21;q22q22)
| | |
|
| | | Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
|
| 7 |
 |
t(15;17)(q24;q21)
| | |
|
| | |
More Descriptions
|
Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
 Acute non lymphocytic leukemias (t-ANLL).
Atypical leukemia M3 ANLL (M3 ANLL).
|
|
|
|
| 8 |
|
ins(15;17)(q22;q21q21)
| | |
|
| | | Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
|
| 9 |
|
t(15;17)(q21;q21)
| | |
|
| | | Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
|
| 10 |
|
t(15;17)(q22;q21)
| | |
|
| | |
|
More Descriptions
|
Bilineage or biphenotypic leukemia (BAL/AL bi).
Acute myeloid leukemia, NOS (AML NOS).
Acute myeloblastic leukemia without maturation (FAB type M1) (AML M1).
Acute myeloblastic leukemia with maturation (FAB type M2) (AML M2).
Acute promyelocytic leukemia (FAB type M3) (APML/APL/AML M3).
Acute myelomonocytic leukemia (FAB type M4) (AMMoL/AML M4).
Acute erythroleukemia (FAB type M6) (AML M6).
Chronic myeloid leukemia, t(9;22) (CML t(9;22)).
Nonneoplastic hematologic disorder/lesion (Nonneo hem).
Acute Myelocytic Leukemia-M3.
T-Cell Acute promyelocytic leukemia.
|
|
|
|
D015470